M&A buy-side
Acquiring the right company today is a great way to grow fast and prepare yourself for tomorrow’s success. Our global presence and local roots, together with a deep understanding of evolving trends, give you a world of opportunities to expand into new markets — and rise above your competition.
Contact advisor
Sopharma Group has acquired two pharmaceutical products in Poland
Sopharma Group has acquired Coffepirine and Kopiryna, two highly recognized medicines to treat headache. The acquisition will further expand the market presence of Sopharma Group in the Polish market and support the promising potential of the two pharmaceutical drugs.
Learn moreSopharma has agreed to acquire Pharmanova, a Serbian-based pharmaceutical company
Sopharma has signed a contract for the phased acquisition of the Serbian-based pharmaceutical manufacturer Pharmanova. The deal is structured in three steps, starting with the acquisition of 25% interest in December 2023, which is increased to 75% in 2024 and to 100% in 2025. With this transaction, Sopharma will further strengthen its market position in the Balkans and add to its family of businesses one of the biggest producers of branded herbal medicines and dietary products in Serbia.
Learn moreLuigi Lavazza SpA has acquired Onda Coffee Break
Lavazza, one of the largest espresso coffee producers in the world, has acquired Onda Coffee Break, the leading coffee shop chain in Bulgaria, for an undisclosed consideration.
Learn more